SEC Comment Letter 0000000000-24-012179 to Bioventus Inc. (BVS) (CIK 0001665988) (BVS)
Bioventus Inc. (BVS) (CIK 0001665988)
Date: Nov. 1, 2024 · CIK: 0001665988 · Accession: 0000000000-24-012179
AI Filing Summary & Sentiment
File numbers found in text: 333-282836
Letter
November 1, 2024 Robert E. Claypoole President and Chief Executive Officer Bioventus Inc. 4721 Emperor Boulevard, Suite 100 Durham, NC 27703 Re:Bioventus Inc. Registration Statement on Form S-3 Filed October 25, 2024 File No. 333-282836 Dear Robert E. Claypoole: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Nicholas O'Leary at 202-551-4451 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc:Wesley Holmes, Esq.
Show Raw Text
November 1, 2024
Robert E. Claypoole
President and Chief Executive Officer
Bioventus Inc.
4721 Emperor Boulevard, Suite 100
Durham, NC 27703
Re:Bioventus Inc.
Registration Statement on Form S-3
Filed October 25, 2024
File No. 333-282836
Dear Robert E. Claypoole:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Nicholas O'Leary at 202-551-4451 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:Wesley Holmes, Esq.